21-31667299-G-C
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000454.5(SOD1):c.281G>C(p.Gly94Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G94D) has been classified as Pathogenic.
Frequency
Consequence
NM_000454.5 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis type 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spastic tetraplegia and axial hypotonia, progressiveInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000454.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SOD1 | NM_000454.5 | MANE Select | c.281G>C | p.Gly94Ala | missense | Exon 4 of 5 | NP_000445.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SOD1 | ENST00000270142.11 | TSL:1 MANE Select | c.281G>C | p.Gly94Ala | missense | Exon 4 of 5 | ENSP00000270142.7 | ||
| SOD1 | ENST00000389995.4 | TSL:3 | c.224G>C | p.Gly75Ala | missense | Exon 4 of 5 | ENSP00000374645.4 | ||
| SOD1 | ENST00000470944.1 | TSL:2 | n.1209G>C | non_coding_transcript_exon | Exon 4 of 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251484 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 1 Pathogenic:2
This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 94 of the SOD1 protein (p.Gly94Ala). This variant is present in population databases (rs121912438, gnomAD 0.002%). This missense change has been observed in individual(s) with familial amyotrophic lateral sclerosis (PMID: 8446170, 15258228, 23541756). This variant is also known as p.Gly93Ala or G93A. ClinVar contains an entry for this variant (Variation ID: 14760). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SOD1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SOD1 function (PMID: 8650157, 12482932, 15050437, 15208263, 19483195, 33381076). This variant disrupts the p.Gly94 amino acid residue in SOD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9029070, 18273717, 21120636, 24325798). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at